Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines

被引：1
|
作者：
Sanchez de Prada, Laura [1 ]
Sanz Munoz, Ivan [2 ]
Castrodeza Sanz, Javier [1 ]
Ortiz de Lejarazu Leonardo, Raul [2 ]
Eiros Bouza, Jose Maria [2 ,3 ]
机构：
[1] Univ Valladolid, Hosp Clin, Valladolid 47003, Spain
[2] Ctr Nacl Gripe Valladolid, Valladolid 47009, Spain
[3] Hosp Univ Rio Hortega Valladolid, Valladolid 47012, Spain
来源：
VACCINES | 2020年 / 8卷 / 04期
关键词：
influenza A; Vaccines; adjuvanted Vaccines; SEASONAL INFLUENZA; INFECTION; VACCINATION; MORTALITY;
D O I：
10.3390/vaccines8040704
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Background: vaccination is the best approach to prevent influenza infections so far. Serological studies on the effect of different vaccine types are important to address vaccination campaigns and protect our population. In our study, we compared the serological response against influenza A subtypes using the non-adjuvanted influenza vaccine (NAIV) in adults and the elderly and the adjuvanted influenza vaccine (AIV) in the elderly. Methods: We performed a retrospective analysis by hemagglutination inhibition assay (HI) of serum samples right before and 28 days after seasonal influenza vaccination during the 1996-2017 seasons. Conclusions: The AIV presents better performance against the A(H3N2) subtype in the elderly whereas the NAIV induces a better response against A(H1N1)pdm09 in the same group.
引用
收藏
页码：1 / 11
页数：11
相关论文
共 50 条
  • [21] Influenza H3N2 Vaccines: Recent Challenges
    Mostafa, Ahmed
    Pleschka, Stephan
    TRENDS IN MICROBIOLOGY, 2018, 26 (02) : 87 - 89
  • [22] Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 US Communities
    Griffin, Marie R.
    Monto, Arnold S.
    Belongia, Edward A.
    Treanor, John J.
    Chen, Qingxia
    Chen, Jufu
    Talbot, H. Keipp
    Ohmit, Suzanne E.
    Coleman, Laura A.
    Lofthus, Gerry
    Petrie, Joshua G.
    Meece, Jennifer K.
    Hall, Caroline Breese
    Williams, John V.
    Gargiullo, Paul
    Berman, LaShondra
    Shay, David K.
    PLOS ONE, 2011, 6 (08):
  • [23] Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines
    DeStefano, Frank
    Vellozzi, Claudia
    Schonberger, Lawrence B.
    Chen, Robert T.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [24] Comparison of the Adverse Events Associated with MF59-Adjuvanted and Non-Adjuvanted H1N1 Vaccines in Healthy Young Male Korean Soldiers
    Hwang, Se-Min
    Kim, Hack-Lyoung
    Min, Kyueng-Whan
    Kim, Min
    Lim, Jae-Sung
    Choi, Jin-Man
    Chun, Byung-Chul
    Kim, Min-Jeong
    Lee, Sang-Min
    Kim, Seung-Young
    Jeon, Han-Ho
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2012, 65 (03) : 193 - 197
  • [25] Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
    Ruiz-Palacios, Guillermo M.
    Leroux-Roels, Geert
    Beran, Jiri
    Devaster, Jeanne-Marie
    Esen, Meral
    Launay, Odile
    McElhaney, Janet E.
    van Essen, Gerrit A.
    Benoit, Anne
    Claeys, Carine
    Dewe, Walthere
    Durand, Christelle
    Duval, Xavier
    Falsey, Ann R.
    Feldman, Gregory
    Galtier, Florence
    Gervais, Pierre
    Hwang, Shinn-Jang
    McNeil, Shelly
    Richardus, Jan Hendrik
    Trofa, Andrew
    Oostvogels, Lidia
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (12) : 3043 - 3055
  • [26] Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses
    Abente, Eugenio J.
    Rajao, Daniela S.
    Santos, Jefferson
    Kaplan, Bryan S.
    Nicholson, Tracy L.
    Brockmeier, Susan L.
    Gauger, Phillip C.
    Perez, Daniel R.
    Vincent, Amy L.
    JOURNAL OF VIROLOGY, 2018, 92 (22)
  • [27] Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children
    Meier, S.
    Bel, M.
    L'huillier, A.
    Crisinel, P. A.
    Combescure, C.
    Kaiser, L.
    Grillet, S.
    Posfay-Barbe, K.
    Siegrist, C. A.
    SWISS MEDICAL WEEKLY, 2011, 141 : 16S - 16S
  • [28] Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children
    Meier, Sara
    Bel, Michael
    L'Huillier, Arnaud
    Crisinel, Pierre-Alex
    Combescure, Christophe
    Kaiser, Laurent
    Grillet, Stephane
    Posfay-Barbe, Klara
    Siegrist, Claire-Anne
    VACCINE, 2011, 29 (19) : 3548 - 3557
  • [29] Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains
    Camilloni, Barbara
    Basileo, Michela
    Di Martino, Angela
    Donatelli, Isabella
    Iorio, Anna Maria
    IMMUNITY & AGEING, 2014, 11
  • [30] Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains
    Barbara Camilloni
    Michela Basileo
    Angela Di Martino
    Isabella Donatelli
    Anna Maria Iorio
    Immunity & Ageing, 11
12345